Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03543371
Other study ID # CardiacArrestLundNeuropsych
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 13, 2018
Est. completion date May 23, 2022

Study information

Verified date September 2023
Source Region Skane
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study is a sub-study to the large pragmatic Target Temperature Management 2 Trial (TTM2-trial, ClinicalTrials.gov Identifier: NCT02908308), assessing effectiveness of controlled hypothermia after out-of-hospital cardiac arrest (OHCA). This study is designed to provide detailed information on cognition after OHCA and its relationship to associated factors as emotional function, fatigue, and sleep. A secondary aim is to utilize this information to validate a neurocognitive screening battery used 6 months after OHCA in the TTM2-trial. Approximately 7 and 24 months after OHCA, survivors at selected TTM2 study sites will perform a standardized neuropsychological assessment including performance-based tests of cognition and questionnaires of behavioral and emotional function, fatigue, and insomnia. At 1:1 ratio, a control group of myocardial infarction (MI) patients but no occurrence of cardiac arrest will be recruited and perform the same test battery. Group differences at 7 and 24 months will be analyzed per cognitive domain (verbal, visual/constructive, short-term working memory, episodic memory, processing speed, executive functions). Results of the OHCA survivors on the TTM2 neurocognitive screening battery will be compared with neuropsychological test results at 7 months time.


Recruitment information / eligibility

Status Completed
Enrollment 200
Est. completion date May 23, 2022
Est. primary completion date January 11, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - OHCA of a presumed cardiac or unknown cause (OHCA cohort only) - Sustained return of spontaneous circulation (ROSC) during intensive care - defined as 20 minutes with signs of circulation without the need for chest compressions (OHCA cohort only) - Unconsciousness - defined as not being able to obey verbal commands (FOUR-score motor response of <4) and no verbal response to pain after sustained ROSC (OHCA cohort only) - Inclusion within 180 minutes of ROSC (OHCA cohort only) - During intensive care - eligible for intensive care without restrictions or limitations (OHCA cohort only) - MI with performed coronary angiography (MI cohort only) Exclusion Criteria: - Temperature on admission <30°C (OHCA cohort only) - On extracorporeal membrane oxygenation (ECMO) prior to return of spontaneous circulation (OHCA cohort only) - Obvious or suspected pregnancy - Intracranial bleeding (OHCA cohort only) - Severe chronic obstructive pulmonary disorder (COPD) with long-term home oxygen therapy - Clinical dementia diagnosis before the event - Inability to speak the local language well enough to complete the assessment without assistance from an interpreter - Inability to meet for a face-to-face examination - Clinical Frailty Scale Index =8, indicating very severe frailty - Cardiac arrest before or in connection with MI (MI cohort only) - Active substance abuse

Study Design


Intervention

Diagnostic Test:
Neuropsychological assessment
Standardized neuropsychological battery consisting of the following tests and questionnaires: Wechsler Adult Intelligence Scale - Fourth Edition (WAIS-IV) Vocabulary, Delis-Kaplan Executive Function System (D-KEFS) Verbal Fluency, WAIS-IV Block Design, WAIS-IV Matrix Reasoning, WAIS-IV Digit Span, Wechsler Memory Scale - Third Edition (WMS-III) Spatial Span, Rey Auditory Verbal Learning Test (RAVLT), WMS-III Logical Memory, Brief Visuospatial Memory Test-Revised (BVMT-R), Trail Making Test (TMT) A & B, D-KEFS Color Word Interference Test, Behavioral Assessment of the Dysexecutive Syndrome Dysexecutive Questionnaire (BADS DEX), Multidimensional Fatigue Inventory (MFI-20), Minimal Insomnia Symptom Scale (MISS), Hospital Anxiety and Depression Scale (HADS).

Locations

Country Name City State
Denmark Aarhus University Hospital Aarhus
Sweden Sahlgrenska University Hospital Göteborg
Sweden Halmstad County Hospital Halmstad
Sweden Helsingborg Hospital Helsingborg
Sweden Skane University Hospital Lund
Sweden Skane University Hospital Malmö
United Kingdom The Essex Cardiothoracic Centre, Basildon and Thurrock University Hospitals NHS Foundation Trust Basildon Essex
United Kingdom University Hospital of Wales, Cardiff and Vale University Health Board Cardiff Wales

Sponsors (7)

Lead Sponsor Collaborator
Region Skane Aarhus University Hospital, Cardiff and Vale University Health Board, Halmstad County Hospital, Lund University, Mid and South Essex NHS Foundation Trust, Sahlgrenska University Hospital, Sweden

Countries where clinical trial is conducted

Denmark,  Sweden,  United Kingdom, 

References & Publications (2)

Blennow Nordstrom E, Lilja G, Vestberg S, Ullen S, Friberg H, Nielsen N, Heimburg K, Evald L, Mion M, Segerstrom M, Grejs AM, Keeble T, Kirkegaard H, Ljung H, Rose S, Wise MP, Rylander C, Unden J, Cronberg T. Neuropsychological outcome after cardiac arrest: a prospective case control sub-study of the Targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest trial (TTM2). BMC Cardiovasc Disord. 2020 Oct 7;20(1):439. doi: 10.1186/s12872-020-01721-9. — View Citation

Blennow Nordstrom E, Vestberg S, Evald L, Mion M, Segerstrom M, Ullen S, Bro-Jeppesen J, Friberg H, Heimburg K, Grejs AM, Keeble TR, Kirkegaard H, Ljung H, Rose S, Wise MP, Rylander C, Unden J, Nielsen N, Cronberg T, Lilja G. Neuropsychological outcome af — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Change in cognitive function Longitudinal change in cognitive function in OHCA and MI patients, analyzed with a mixed model regression. 7 months, 24 months after the cardiac event
Primary Cognitive impairment Cognitive function in OHCA and MI patients, using composite z-scores from the neuropsychological tests grouped by cognitive domain. 7 months after the cardiac event
Secondary Sensitivity and specificity of the neurocognitive screening battery in the main TTM2-trial Validation of the neurocognitive screening battery in OHCA patients, using the detailed neuropsychological test battery as a gold standard with sensitivity and specificity analyses. Here, patients will be considered to have a cognitive impairment if they meet any of the following criteria on the neuropsychological tests: 1) an impaired composite z-score defined as z = - 1.65 in at least one cognitive domain; 2) z = - 1.65 in at least two scores used for cognitive domain calculation. Cut-scores for indicated impairment on the neurocognitive screening battery will be < 26 on the MoCA, z=-1 on the SDMT, =3.08 on the IQCODE-CA and the answer "no" to question 2 at the TSQ. 7 months post-arrest
See also
  Status Clinical Trial Phase
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT05963542 - Efficacy of Online Acceptance and Commitment Therapy and Sound Therapy for Patients With Tinnitus and Insomnia N/A
Completed NCT06339853 - Study of Efficacy of Digital Cognitive Behavioral Therapy With Wearable Device for Insomnia N/A
Recruiting NCT04069247 - Effectiveness of eCBT-I on Improving Mental Health in Chinese Youths With Insomnia N/A
Completed NCT04493593 - Internet-delivered CBT-I (Space for Sleep): Pilot and Feasibility N/A
Recruiting NCT06278077 - Neurexan - a Clinical Trial in Short-Term Insomnia Patients Phase 2
Recruiting NCT05956886 - Sleep Chatbot Intervention for Emerging Black/African American Adults N/A
Completed NCT04661306 - The Better Sleep for Supporters With Insomnia Study N/A
Recruiting NCT06207279 - Preliminary Study on the Development and Reliability and Validity of Attention Rating Scale
Recruiting NCT06006299 - Investigating the Use of taVNS to Treat Insomnia in Individuals With Breast Cancer (taVNS-insomnia-BC) N/A
Completed NCT03683381 - App-based Intervention for Treating Insomnia Among Patients With Epilepsy N/A
Completed NCT04564807 - Testing an Online Insomnia Intervention N/A
Completed NCT03673397 - The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression N/A
Completed NCT04035200 - Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation Phase 2
Active, not recruiting NCT05027438 - Reducing Use of Sleep Medications Assisted by a Digital Insomnia Intervention N/A
Recruiting NCT06053840 - An Open-label Trial to Evaluate the Safety and Efficacy of Chloral Hydrate in Patients With Severe Insomnia Phase 4
Not yet recruiting NCT06348082 - Project Women's Insomnia Sleep Health Equity Study (WISHES) N/A
Not yet recruiting NCT06363799 - Osteopathic Protocol for Insomnia in College Students N/A
Not yet recruiting NCT06025968 - Digital Cognitive-behavioral Therapy for Insomnia for Patients With Multiple Sclerosis N/A
Not yet recruiting NCT05991492 - Improving Sleep With a Digital Cognitive Behavioral Therapy for Insomnia Application N/A